Related Experiment Video
Updated: Jun 2, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Study on the Synergistic Effect of Klotho and KRAS on Reducing Ferroptosis After Myocardial Infarction by Regulating
ChengZhe Cai1, YiQin Wu1, XiaoQian Feng1
1Department of Internal Medicine-Cardiovascular, Guangzhou Twelfth People's Hospital, No.1, Tianqiang Road, Tianhe District, Guangzhou City, Guangdong Province, 510620, China.
Insights
Klotho protein deficiency exacerbates myocardial infarction (MI) and ferroptosis by promoting oxidative stress. Restoring Klotho function, through interaction with KRAS and regulation of the RAP1/ERK pathway, mitigates MI-induced ferroptosis.
Area of Science:
- Cardiovascular Biology
- Cell Death Mechanisms
- Molecular Medicine
Background:
- Myocardial infarction (MI) is a leading cause of sudden death, characterized by cardiomyocyte death due to nutrient and oxygen deprivation.
- Ferroptosis, a form of regulated cell death driven by metabolic dysfunction and iron-dependent reactive oxygen species (ROS) accumulation, is implicated in MI pathogenesis.
- The roles of Klotho and KRAS in MI-associated ferroptosis remain largely undefined.
Purpose of the Study:
- To elucidate the molecular mechanisms of ferroptosis in myocardial infarction (MI).
- To investigate the functional roles of Klotho and KRAS in ferroptosis during MI.
- To explore the interaction between Klotho and KRAS and their regulation of the RAP1/ERK pathway in MI.
Main Methods:
- Established MI rat models via LAD ligation and an in vitro oxygen-glucose deprivation (OGD) model using H9c2 cells.
- Assessed myocardial injury, apoptosis, and ferroptosis markers (e.g., ROS, GSH, LDH, CK-MB, cTnT, PTGS2) using histological staining, Western Blot, RT-qPCR, IHC, CCK-8, and ELISA assays.
- Investigated Klotho-KRAS interaction via co-immunoprecipitation and Western Blot; analyzed the RAP1/ERK pathway.
Main Results:
- Klotho was downregulated in MI, and its deficiency aggravated myocardial injury, cardiomyocyte apoptosis, and ferroptosis.
- Klotho deficiency increased ROS and pro-ferroptotic markers while decreasing antioxidant GSH levels.
- Klotho and KRAS exhibited an endogenous interaction; KRAS knockdown reversed Klotho knockdown-induced MI and ferroptosis. Inhibition of the RAP1/ERK pathway counteracted KRAS-mediated MI progression and ferroptosis.
Conclusions:
- Klotho interacts with KRAS and plays a protective role against ferroptosis in myocardial infarction.
- Klotho inhibits MI-induced ferroptosis by regulating the RAP1/ERK signaling pathway.
- Targeting the Klotho-KRAS-RAP1/ERK axis presents a potential therapeutic strategy for managing myocardial infarction.
Abstract:
Myocardial infarction (MI) is a coronary artery-related disease that seriously threatens human life and is the leading cause of sudden death worldwide, where a lack of nutrients and oxygen leads to an inflammatory response and death of cardiomyocytes. Ferroptosis is a form of non-apoptotic cell death associated with metabolic dysfunction, resulting in abnormal breakdown of glutamine and iron-dependent accumulation of reactive oxygen species (ROS) during metabolism. However, the molecular mechanism of ferroptosis in the pathogenesis of MI and the function of Klotho and KRAS on ferroptosis during MI remain unclear. The MI rat model was established by LAD ligation with a 6-0 suture. H9c2 cells were placed in glucose-deficient DMEM (Thermo) and cultured in an anaerobic environment (1% CO2 and 5% CO) to establish an in vitro OGD cell model. The damage to rat heart tissue was detected by HE staining, and Klotho and KRAS were determined by RT-qPCR, Western Blot, and IHC. TUNEL staining was used to determine apoptosis in rat heart tissue samples. The interaction between Klotho and KRAS was verified by co-immunoprecipitation and Western Blot. The cardiomyocyte activity was measured by CCK-8 assay. LDH, CK-MB, cTnT, and Fe2+ markers were detected by the kits. For the assessment of ferroptosis, GSH and ROS in cardiomyocytes and serum were detected by kits, and PTSG was detected by Western Blot. IL-1β and IL-6 in cardiomyocytes and serum were determined by ELISA. Klotho was downregulated in MI. Downregulation of Klotho promoted myocardial injury; increased apoptosis of cardiomyocytes; promoted LDH, CK-MB, and cTnT concentrations; inhibited GSH; and promoted ROS levels, PTGS2 expression, and ferroptosis in rats. The same results were obtained in vitro. Klotho and KRAS had endogenous interactions. KRAS knockdown can reverse Klotho knockdown-mediated MI and ferroptosis. RAP1/ERK pathway was highly expressed in MI, and inhibiting RAP1/ERK pathway activation can reverse the promoting effect of overexpressed KRAS on MI progression and ferroptosis. Klotho interacts with KRAS and inhibits ferroptosis after MI by regulating the RAP1/ERK pathway.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
08:00Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019